Evidence map›Paper›PMID 39031976›Full record

ReviewCancer science2024

The role of gastric mucins and mucin-related glycans in gastric cancers.

Junya Arai, Yoku Hayakawa, Hiroaki Tateno, Hiroaki Fujiwara, Masato Kasuga, Mitsuhiro Fujishiro

Abstract readReview
In one paragraph

Review in Cancer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Monoclonal stool antigen test for diagnosingFrontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Article
  7. CAR-T cell therapy targeting MUC17 in gastric tumors.Journal for immunotherapy of cancer · 2025
    Article
  8. Article
  9. Extraction of Active Compounds fromMaterials (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Junya AraiDivision of Gastroenterology, The Institute for Medical Science, Asahi Life Foundation, Chuo-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4905-7046
Yoku HayakawaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3988-2499
Hiroaki TatenoCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
Hiroaki FujiwaraDivision of Gastroenterology, The Institute for Medical Science, Asahi Life Foundation, Chuo-ku, Tokyo, Japan.
Masato KasugaThe Institute for Medical Science, Asahi Life Foundation, Chuo-ku, Tokyo, Japan.
Mitsuhiro FujishiroDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Funding

Advanced Research and Development Programs for Medical Innovation (PRIME)Japan Society for the Promotion of Science 23H02744Japan Society for the Promotion of Science 24K18531Kato Memorial Bioscience FoundationP-CREATE/PROMOTE from AMED
6 · The paper itself

Abstract

Gastric mucins serve as a protective barrier on the stomach's surface, protecting from external stimuli including gastric acid and gut microbiota. Their composition typically changes in response to the metaplastic sequence triggered by Helicobacter pylori infection. This alteration in gastric mucins is also observed in cases of gastric cancer, although the precise connection between mucin expressions and gastric carcinogenesis remains uncertain. This review first introduces the relationship between mucin expressions and gastric metaplasia or cancer observed in humans and mice. Additionally, we discuss potential pathogenic mechanisms of how aberrant mucins and their glycans affect gastric carcinogenesis. Finally, we summarize challenges to target tumor-specific glycans by utilizing lectin-drug conjugates that can bind to specific glycans. Understanding the correlation and mechanism between these mucin expressions and gastric carcinogenesis could pave the way for new strategies in gastric cancer treatment.

Indexed as

Gastric MucinsHelicobacter InfectionsPolysaccharidesStomach NeoplasmsAnimalsCarcinogenesisGastric MucosaHelicobacter pyloriHumansMetaplasiaMiceGastric MucinsPolysaccharidesgastric cancergastric mucinglycansHelicobacter pyloriintestinal metaplasia

Identifiers

PMID39031976
PMCPMC11463072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.